[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338701-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338701-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","stemness-of-cancer-a-study-of-triple-negative-breast-cancer-from-a-neuroscience-perspective","Stemness of Cancer - A Study of Triple-negative Breast Cancer From a Neuroscience Perspective","","Cancer stemness confers extensive plasticity that helps tumour cells endure dynamic stresses such as hypoxia and develop resistance, particularly to chemotherapy. This study reviews key mechanisms behind cancer stemness with a focus on triple-negative breast cancer (TNBC), including stemness-associated gene programs and the Yamanaka factors, highlighting roles of c-Myc and the Nav1.5 neonatal splice variant. Strategies that reduce stemness may lower invasiveness, metastasis and restore chemosensitivity through gene silencing, epigenetic therapies and optogenetic bioelectric modulation, followed by clinical exploitation and diagnostic and therapeutic perspectives such as personalised mRNA approaches and cancer neuroscience.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/stemness-of-cancer-a-study-of-triple-negative-breast-cancer-from-a-neuroscience-perspective/338701/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/stemness-of-cancer-a-study-of-triple-negative-breast-cancer-from-a-neuroscience-perspective/338701.png","ImageObject",300,407,{"name":42,"@type":43},"Valentina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does cancer stemness enable tumour cells to do?","Question",{"text":63,"@type":64},"Cancer stemness grants tumour cells massive plasticity, helping them survive dynamic conditions such as hypoxia and become resistant to treatments, especially chemotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is triple-negative breast cancer highlighted in the review?",{"text":68,"@type":64},"The review focuses on triple-negative breast cancer (TNBC) because it is described as the most aggressive form of breast cancers and as a model where stemness-linked mechanisms are prominent.",{"name":70,"@type":61,"acceptedAnswer":71},"How can reducing stemness affect cancer behavior and treatment response?",{"text":72,"@type":64},"Measures that reduce stemness are described as making cancer cells less aggressive, lowering invasive/metastatic potential and increasing or restoring chemosensitivity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338701,1790377838,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Stemness of Cancer: A Study of Triple-negative Breast Cancer From a Neuroscience Perspective  \nMustafa B. A. Djamgoz1  \nAccepted: 21 October 2024 / Published online: 12 November 2024 © The Author(s) 2024  \nAbstract  \nStemness, giving cancer cells massive plasticity enabling them to survive in dynamic (e.g. hypoxic) environments and become resistant to treatment, especially chemotherapy, is an important property of aggressive tumours. Here, we review some essentials of cancer stemness focusing on triple-negative breast cancer (TNBC), the most aggressive form of all breast cancers. TNBC cells express a range of genes and mechanisms associated with stemness, including the fundamental four “Yamanaka factors”. Most of the evidence concerns the transcription factor / oncogene c-Myc and an interesting case is the expression of the neonatal splice variant of voltage-gated sodium channel subtype Nav1.5 . On the whole, measures that reduce the stemness make cancer cells less aggressive, reducing their invasive/metastatic potential and increasing/ restoring their chemosensitivity. Such measures include gene silencing techniques, epigenetic therapies as well as novel approaches like optogenetics aiming to modulate the plasma membrane voltage. Indeed, simply hyperpolarizing their membrane potential can make stem cells differentiate. Finally, we give an overview of the clinical aspects and exploitation of cancer/TNBC stemness, including diagnostics and therapeutics. In particular, personalised mRNA-based therapies and mechanistically meaningful combinations are promising and the emerging discipline of ‘cancer neuroscience’ is providing novel insights to both fundamental issues and clinical applications.  \nKeywords Oncofoetal · Hypoxia · Drug resistance · Ion channel · Splicing · Autoantibody · Neuroscience · Antibody · Tumour microenvironment · Epigenetics · Bioelectricity · Diagnostics · Electrotherapy  \nGeneral Introduction  \nCancer now is one of the most common causes of death with 1 in 2–3 people diagnosed with the disease in some form during their lifetime. The annual number of cancer diagnoses worldwide is expected to rise to some 28 million, while the number of cancer-related deaths to 16 million by 2040 [1] . In all solid tumours, except gliomas, a prominent cause of death is metastasis, the complex process in which cancer cells escaping from primary tumours ultimately invade secondary sites giving rise to organ failure. Many problems remain in clinical management of cancer, especially difficulty of early, functional diagnosis and long-term effective therapy without undesirable side effects. Regarding the  \n􀀍 Mustafa B. A. Djamgoz [m.djamgoz@imperial.ac.uk](m.djamgoz@imperial.ac.uk)  \n1 Department of Life Sciences, Imperial College London, South Kensington Campus, London SW7 2AZ, UK  \nlatter, the situation is worse for metastatic disease since it often necessitates systemic treatment with cytotoxic drugs to which resistance then develops over time.  \nCancer cells/tissues demonstrate varying degrees of dedifferentiation, and many genes therein are (re)expressed in their embryonic (“oncofoetal”) forms [e.g. 2] . Thus, cancer cells have inherent stemness and, consequently, tumours are heterogenous in their cellular make-up. An obvious case of dedifferentiation / stemness can be seen in a type of germcell cancer called “teratocarcinoma”. These are rare tumours the embryonic nature of which can result in differentiation into different types of adult tissue such as bone, teeth, muscle and hair [3] . On the whole, the degree of dedifferentiation is positively correlated with the aggressiveness of the tumour, but this may vary from cancer to cancer [e.g. 4] .  \nIt is not clear why de-differentiation occurs in cancer. One possibility is that it is a response to the pathological change and the body’s attempt to reverse the ‘damage’ by reverting the cancer tissue back its embryonic form, soit can rebuild itself normally. A similar phenomenon o","cbCaihjZZO8DFaJJ","https://ap.wps.com/l/cbCaihjZZO8DFaJJ","pdf",1391058,14,"English","# Abstract\n# General Introduction\n## Cancer epidemiology and metastasis\n## Dedifferentiation, oncofoetal gene expression and teratocarcinoma\n## Hypoxia-linked stemness and tumour progression\n## Cancer stem cells, plasticity and resistance mechanisms\n## Treatments that target stemness","[{\"question\":\"What does cancer stemness enable tumour cells to do?\",\"answer\":\"Cancer stemness grants tumour cells massive plasticity, helping them survive dynamic conditions such as hypoxia and become resistant to treatments, especially chemotherapy.\"},{\"question\":\"Why is triple-negative breast cancer highlighted in the review?\",\"answer\":\"The review focuses on triple-negative breast cancer (TNBC) because it is described as the most aggressive form of breast cancers and as a model where stemness-linked mechanisms are prominent.\"},{\"question\":\"How can reducing stemness affect cancer behavior and treatment response?\",\"answer\":\"Measures that reduce stemness are described as making cancer cells less aggressive, lowering invasive/metastatic potential and increasing or restoring chemosensitivity.\"}]","Stemness of Cancer - A Study of Triple-negative Breast Cancer From a Neuroscience Perspective | PDF",1790025162,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c4ed4950553fa5cf854f4fa5545c1f9.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d21693d9021363e00cb8eca58191ef5.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec90dce43b1b8b07d44aa20b4f20acfd.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b00a8353eac7c8e52fcb916e68bf3df.webp",980,1301]